Save Comparison | ![]() Northwest Biotherapeutics Northwest Biotherapeutics is a biotechnology company focused on developing and commercializing immunotherapy products to treat cancer. | ![]() CytomX Therapeutics CytomX is an oncology-focused biopharmaceutical company pioneering a novel class of antibody therapeutics based on Probody technology platform. | ![]() AVEO Pharmaceuticals AVEO is a biopharmaceutical company focused on the discovery and development of targeted cancer therapeutics. | |
Founding Date | Founding Date 2005 | Founding Date 1998 | Founding Date 2008 | Founding Date 2001 |
Type | Type Public | Type Public | Type Public | Type Public |
Tags | ||||
Locations | Locations Baton Rouge, US HQ | Locations Bethesda, US HQ | Locations South San Francisco, US HQ | Locations Cambridge, US HQ Boston, US |
Employees | Employees 3 | Employees 1721% increase | Employees 15815% increase | Employees 1912% increase |
Valuation ($) | Valuation ($) 320.2 k | Valuation ($) 1.2 b | Valuation ($) 307.4 m | Valuation ($) 241.7 m |
Twitter followers | Twitter followers 2.4 k | Twitter followers 2.3 k | Twitter followers 889 | Twitter followers 907 |
Alexa Website Rank | Alexa Website Rank N/A | Alexa Website Rank 616184 | Alexa Website Rank 281860 | Alexa Website Rank 419832 |
Employee Rating | Employee Rating N/A | Employee Rating N/A | Employee Rating 3.4 | Employee Rating 3.7 |
Financial | ||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $2.4m (FY, 2019) | Revenue (est.) $57.5m (FY, 2019) | Revenue (est.) $28.8m (FY, 2019) |
Net income | Net income ($9.4m) (FY, 2019) | Net income ($20.3m) (FY, 2019) | Net income ($102.2m) (FY, 2019) | Net income $9.4m (FY, 2019) |
Funding | ||||
Total funding raised | Total funding raised N/A | Total funding raised $ 135.9m | Total funding raised $ 132.4m | Total funding raised $ 224m |
Northwest Biotherapeutics is a biotechnology company focused on developing and commercializing immunotherapy products to treat cancer.
View companyCytomX is an oncology-focused biopharmaceutical company pioneering a novel class of antibody therapeutics based on Probody technology platform.
View companyAVEO is a biopharmaceutical company focused on the discovery and development of targeted cancer therapeutics.
View company